Cited by 966IL-33, ST2, and ILC PathwaysCytokine Signaling Pathways and InteractionsGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Open access

Carriere, Virginie, Roussel, Lucie, Ortega, Nathalie, Lacorre, Delphine-Armelle, Americh, Laure, Aguilar, Luc, Bouche, Gérard, Girard, Jean-Philippe·2007·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0606854104PMC PMC1765450

Open this paper in CoChat — free account

Abstract

Recent studies indicate that IL-1α functions intracellularly in pathways independent of its cell surface receptors by translocating to the nucleus and regulating transcription. Similarly, the chromatin-associated protein HMGB1 acts as both a nuclear factor and a secreted proinflammatory cytokine. Here, we show that IL-33, an IL-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, is an endothelium-derived, chromatin-associated nuclear factor with transcriptional repressor properties. We found that IL-33 is identical to NF-HEV, a nuclear factor preferentially expressed in high endothelial venules (HEV), that we previously characterized. Accordingly, in situ hybridization demonstrated that endothelial cells constitute a major source of IL-33 mRNA in chronically inflamed tissues from patients with rheumatoid arthritis and Crohn's disease. Immunostaining with three distinct antisera, directed against the N-terminal part and IL-1-like C-terminal domain, revealed that IL-33 is a heterochromatin-associated nuclear factor in HEV endothelial cells in vivo . Association of IL-33 with heterochromatin was also observed in human and mouse cells under living conditions. In addition, colocalization of IL-33 with mitotic chromatin was noted. Nuclear localization, heterochromatin-association, and targeting to mitotic chromosomes were all found to be mediated by an evolutionarily conserved homeodomain-like helix–turn–helix motif within the IL-33 N-terminal part. Finally, IL-33 was found to possess transcriptional repressor properties, associated with the homeodomain-like helix–turn–helix motif. Together, these data suggest that, similarly to IL1α and HMGB1, IL-33 is a dual function protein that may function as both a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0606854104

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
Schmitz, J., Owyang, A. M., Oldham, E. R., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,773
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin.
Brown, K., Guest, S. S., Smale, S., Hahm, K., Merkenschlager, M., & Fisher, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80472-9 · Cited by 824
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & TRAVERS, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 619
Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587

Show all 38 references

Research works printed but not linked: 1

CA Dinarello Eur Cytokine Netw 11, 483–486 (2000).

Sorted by citations

Items 801–900 of 965

Expression of IL‐33 in rodent testes and its role in Leydig cell steroidogenesis and aging
Wang, H., Hu, Y., Li, Z., Wu, E., Yuan, Q., Niu, X., Liu, J., Cai, H., Qin, M., Xu, J., et al. (2025) · Andrology · doi:10.1111/andr.70078 · Cited by 4
Diagnostic accuracy of interleukin-33 for tuberculous pleural effusion
Shi, X., Yi, F., Qiao, X., Pei, X., & Dong, S. (2021) · Medicine · doi:10.1097/md.0000000000026755 · Cited by 4
Orchestrated regulation of immune inflammation with cell therapy in pediatric acute liver injury
Duan, M., Liu, X., Yang, Y., Zhang, Y., Wu, R., Lv, Y., & Lei, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194588 · Cited by 4
Serum, synovial and mRNA expression of interleukin-33 in juvenile idiopathic arthritis patients: Potential role as a marker of disease activity and relation to musculoskeletal ultrasound
El-Deen, E. M. N., Hassan, W. A., Behiry, E. G., & El-monem, A. E.-H. A. (2020) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2020.02.005 · Cited by 4
Knowledge mapping of interleukin-33: a bibliometric study.
Sun, J., Xia, Y., Zhang, D., Yu, Z., Ning, Y., & Tan, Z. (2023) · PubMed Central · Cited by 4
Generation and evaluation of mammalian secreted and membrane protein expression libraries for high-throughput target discovery
Panavas, T., Lu, J. Y., Liu, X., Winkis, A., Powers, G. D., Naso, M. F., & Amegadzie, B. Y. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.05.011 · Cited by 4
Impact of Cytokines in Mast cells Allergic Inflammation
Conti, P. (2013) · Cited by 4
Development of an interleukin (IL)-33 sandwich ELISA kit specific for mature IL-33
Kim, E., Kwak, A., Jhun, H., Lee, S., Jo, S., Lee, J., Kang, T., Her, E., Bae, S., Lee, Y. M., et al. (2016) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2016.1179645 · Cited by 4
The Interleukin-1 Family
Dinarello, C. A., & Netea, M. G. (2013) · Springer eBooks · doi:10.1007/978-4-431-54442-5_1 · Cited by 4
Mechanisms in COPD compared with asthma
Barnes, P. J. (2008) · Breathe · doi:10.1183/18106838/breathe.5.2.134 · Cited by 4
Adventitial Injection of Hyaluronic Acid/Sodium Alginate Hydrogel Loaded With IL-33 Antibody Decreases Neointimal Hyperplasia
Shi, P., Sun, P., Lou, C., Fang, J., Zhang, L., Xie, B., & Zhang, C. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.11.017 · Cited by 3
Cytokine, cytokine storm and their role in fatalities of COVID-19
Roy, S. C. (2021) · Journal of Infectious Diseases and Immunity · doi:10.5897/jidi2021.0216 · Cited by 3
IL-33 deficiency suppresses alveolar bone loss in a ligature-induced periodontitis model
Aida, N., Takeda, K., Nakae, S., Saito, H., Okumura, K., Azuma, T., & Ohno, T. (2023) · Biomedical Research · doi:10.2220/biomedres.44.9 · Cited by 5
The role of the triad of respiratory epithelial cell-derived cytokines in the pathogenesis of allergic rhinitis
Shilovskiy, I. P., Драгановна, Т. Е., Михайловна, К. М., Pasikhov, G. B., Tahanovich, A. D., Kadushkin, A. G., Гудима, Г. О., & Khaitov, M. R. (2024) · Immunologiya · doi:10.33029/1816-2134-2024-45-2-245-255 · Cited by 3
The Crosstalk Between Protective and Detrimental Interleukin (IL)‐1 Family of Cytokines in Alzheimer's Disease
Liu, T., & Li, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70460 · Cited by 3
Unlocking IL-33: New Insights into Tumor Immunity
Kang, B. H., & Lee, H. K. (2025) · Immune Network · doi:10.4110/in.2025.25.e36 · Cited by 3
Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis
Benedetto, C. D., Khan, T., Serrano-Saenz, S., Rodriguez-Lemus, A., Klomsiri, C., Beutel, T.-M., Thach, A., Walczak, H., & Betancur, P. A. (2023) · Cancers · doi:10.3390/cancers15030967 · Cited by 4
IL-33 immunohistochemical pattern of expression in neoplastic and nonneoplastic peripheral lung tissues of stage 1 o 2 lung adenocarcinoma
Casciaro, M., Gangemi, S., Caramori, G., Nucera, F., Tuccari, G., & Ieni, A. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155208 · Cited by 3
Therapeutic targeting of full-length interleukin-33 protein levels with cell-permeable decoy peptides attenuates fibrosis in the bleomycin model in vivo
Atamas, S. P., Lockatell, V., Todd, N. W., Papadimitriou, J. C., Rus, V., Lugkey, K. N., Vogel, S. N., Toshchakov, V. Y., & Luzina, I. G. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002050 · Cited by 3
Increased Plasma ST2 Levels Precede the Development of Severe Acute GvHD and Chronic GvHD After Pediatric Hematopoietic Stem Cell Transplantation
Kamari‐Kany, N., Weischendorff, S., Ifversen, M., Horan, D. E., Enevold, C., Kielsen, K., & Müller, K. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31995 · Cited by 3
Interleukin-33/ST2: A new signaling pathway in immunity and immunopathology
Pavlovic, S. M., Zdravkovic, N. S., Radosavljevic, G. D., Arsenijević, N., Lukić, M. L., & Jovanović, I. (2012) · Vojnosanitetski pregled · doi:10.2298/vsp1201069p · Cited by 3
Cytokines in liver, biliary, and pancreatic disease
Weiss, M. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1454-8.00010-2 · Cited by 3
Cytokines and Chemokines
Turner, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_15 · Cited by 5
Hematopoietic Growth Factors and Cytokines
Ekmekçioglu, S., Kurzrock, R., & Grimm, E. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00057-3 · Cited by 5
Correlation Profile of Suppression of Tumorigenicity 2 and/or Interleukin-33 with Biomarkers in the Adipose Tissue of Individuals with Different Metabolic States
Hasan, A., Kochumon, S., Al‐Ozairi, E., Tuomilehto, J. O., Al‐Mulla, F., & Ahmad, R. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s251978 · Cited by 6
Interleukin-33 and Obesity-Related Inflammation and Cancer
Kowitt, C., & Zhang, Q. (2024) · Encyclopedia · doi:10.3390/encyclopedia4040117 · Cited by 3
Expression and clinical significance of IL-33 and its receptor ST2 in children with obstructive sleep apnea syndrome
Zhang, Z., Li, L., Zhao, L., Liu, G., Han, F., Du, J., & Liu, L. (2022) · Translational Pediatrics · doi:10.21037/tp-21-606 · Cited by 2
Fungal mycobiome-mediated immune response: a non-negligible promoter in pancreatic oncogenesis and chemoresistance
Jiang, Y., Donati, V. L., Peters, G. J., Giovannetti, E., & Deng, D. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.06 · Cited by 2
IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and aging
Naef, P., Jaeger-Ruckstuhl, C. A., Schnüriger, N., Forster, S., Monteiro, I., Brigger, D., Eggel, A., Kessenbrock, K., Riether, C., & Ochsenbein, A. F. (2025) · iScience · doi:10.1016/j.isci.2025.112378 · Cited by 5
Preliminary exploration of efficacy assessment and optimal concentration of teprenone oral rehydration solution for the early management of post-burn shock
Liu, X., Wu, Y., Chai, J., Su, X., Qu, Y., Hu, F.-C., Liu, T., Zheng, J., Han, S., Zhou, H., et al. (2025) · Burns · doi:10.1016/j.burns.2025.107615 · Cited by 2
New Perspectives on Classical Alarmin Responses to Intestinal Helminth Infection
Lynch, C. P., & Grencis, R. K. (2025) · Parasite Immunology · doi:10.1111/pim.70027 · Cited by 2
Adding pieces to the puzzle: IL-33 contribution to fibrogenesis in chronic lung allograft dysfunction
Perea, B., Gambini, C., Paggi, I., Biancucci, S., Cattelan, S., Genovese, M., d’Alessandro, M., Cameli, P., Bargagli, E., Dilroba, A., et al. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157080 · Cited by 2
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression
Bui, T. M., Rojas-Jiménez, E. A., Li, Z., Foidart, P., Puleo, J. I., Yan, P., Jhaveri, A., Yang, L., Nishida, J., Seehawer, M., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.03.015 · Cited by 3
Overview of the Immune System and Immunotoxicology
Lawrence, D. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00601-1 · Cited by 3
Development of Lymph Node Circulation and Homing Mechanisms
Ager, A., Coles, M. C., & Stein, J. V. (2010) · Springer eBooks · doi:10.1007/978-3-642-14429-5_8 · Cited by 2
Interaction Between CD34+ Fibrocytes and Airway Smooth Muscle Promotes IL-8 Production and Akt/PRAS40/mTOR Signaling in Asthma
Lin, T., Chang, P., Lo, C., Lo, Y., Yu, C., Lin, S., Kuo, C. S., & Lin, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.823994 · Cited by 2
Clinical significance of cytokine counting in patients with multiple sclerosis and its relationship with herpes infection
Baranova, N. S., Gris, M. S., Baranov, A. A., Spirin, N., Artyuhov, A., Шакирова, К. М., & Nasonov, E. (2023) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2023.032 · Cited by 3
The IL-33/ST2 Axis Affects Adipogenesis Through Regulating the TRAF6/RelA Pathway
Cao, S., Qin, X., Li, C., Zhang, L., Ren, S., Zhou, W., Zhao, M., & Zhou, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212005 · Cited by 2
From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL ‐33
Obata‐Ninomiya, K., Tharmalingam, J., & Ziegler, S. F. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.70020 · Cited by 2
Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Spontaneous Urticaria and Its Association with Serum Interleukin-33 Levels
Dobrican, C. T., Deleanu, D. M., Iancu, M., Muntean, I. A., Nedelea, I., Bălan, R.-G., Procopciuc, L. M., & Filip, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413709 · Cited by 3
Интерлейкин-33: друг или враг в борьбе против опухоли?
Gorbacheva, A. M., & Mitkin, N. A. (2019) · Molecular Biology · doi:10.1134/s0026898419050069 · Cited by 3
It all happens between Toll receptors and Caspase 1
Sánchez-Alavez, M., & Bartfai, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702505104 · Cited by 2
Potential therapeutic targets from genetic and epigenetic approaches for asthma
Zhang, Y. (2016) · World Journal of Translational Medicine · doi:10.5528/wjtm.v5.i1.14 · Cited by 2
Blockade of Interleukin-33 Attenuates Allergic Contact Dermatitis in Model Mice: Possible Mechanism via Eosinophil Infiltration
Taniguchi, K. (2013) · Journal of Clinical & Experimental Dermatology Research · doi:10.4172/2155-9554.1000183 · Cited by 2
Molecular genetic aspects of polypous rhinosinusitis
Moiseeva, Y. P., & Пискунов, Г. З. (2020) · Russian Rhinology · doi:10.17116/rosrino20202801126 · Cited by 2
Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential
Huang, F. P., Chen, W.-Y., Ma, J., He, X., & Wang, J. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i1.23 · Cited by 2
Cytokines
Lewko, W. M., & Oldham, R. K. (2009) · Springer eBooks · doi:10.1007/978-90-481-2289-9_8 · Cited by 2
[Clinicopathological study of colorectal cancer in young adults including a case of cancer family syndrome].
Ochi, T., Asai, A., Okamura, S., Yamaguchi, H., Ohashi, S., & Mitake, M. (1987) · PubMed · Cited by 2
The role of innate lymphoid cells in the heart and cardiac inflammation
Choi, H. S., Hou, X., Bracamonte‐Baran, W., Diny, N. L., Talor, M. V., & Čiháková, D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.200.supp.42.22 · Cited by 2
Physiological role of the IL-1 family cytokines and receptors in the human brain
Ge, S., Lin, J., Lin, W., Liu, T., Qiao, H., Yang, W., Zhu, L., Babarinde, I. A., Kang, Z., Chu, J., et al. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100204 · Cited by 2
Advances in targeting IL-1 family cytokines for the treatment of inflammatory diseases
Gabay, C., Girard-Guyonvarc’h, C., Vaillant, L., & Jarlborg, M. (2026) · Nature Reviews Rheumatology · doi:10.1038/s41584-026-01395-1 · Cited by 1
Interleukin-33 at the intersection of inflammation and repair
Martinez-Moreno, F., Jerschow, E., Ortega, V., Kita, H., & Chiarella, S. E. (2026) · Frontiers in Allergy · doi:10.3389/falgy.2026.1894127 · Cited by 3
ST2 in Heart Failure: Where Does This New Marker Fit in?
Mallick, A., & Januzzi, J. L. (2015) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-015-0069-7 · Cited by 1
Levels of interleukin 33 and soluble suppression of tumorigenicity 2 in acute ischemic stroke
Yan, J., Lin, C. Y., Pfluger, C. M., & McCombe, P. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12067 · Cited by 1
Asthma and Respiratory Allergic Disease
Lehmann, D. M., & Williams, M. A. (2012) · Molecular and integrative toxicology · doi:10.1007/978-1-61779-812-2_3 · Cited by 1
Immunology of the Asthmatic Response
Palomares, Ó., & Akdiş, C. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00028-8 · Cited by 1
Interleukin-1 Superfamily and Cancer
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00002-6 · Cited by 1
Overview of the Immune System and Immunotoxicology
Lawrence, D. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100601-6.95626-6 · Cited by 1
Innovation through imitation: IL-33 decoys show promise in pulmonary fibrosis
Kotas, M. E., & Gordon, E. D. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2024.100035 · Cited by 1
The curious case of IL‐33 in homeostasis and infection
Nadafi, R., & Arens, R. (2020) · European Journal of Immunology · doi:10.1002/eji.202049031 · Cited by 1
Plasma Interleukin-33 Cannot Predict Hip Osteonecrosis in Patients With Sickle Cell Disease: A Case-Control Study
Agrawal, A. C., Mohapatra, E., Nanda, R., Bodhey, N. K., Sakale, H. S., & Garg, A. K. (2022) · Cureus · doi:10.7759/cureus.23556 · Cited by 1
Investigation of the expression and biological response of the IL-1Rrp2 receptor in human cells
Mutamba, S. (2012) · Nottingham ePrints (University of Nottingham) · Cited by 1
Interleukin-33 and Atherosclerosis
Liew, F. Y., & Miller, A. M. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_12 · Cited by 1
PAs and NPs in an emergency room-linked acute care clinic.
Currey, C. J. (1984) · PubMed · Cited by 1
Hepatic Immunology
Szabó, G., & Bruneau, J. C. (2013) · Wiley eBooks · doi:10.1002/9781118637272.ch2 · Cited by 1
The role of IL-33 and IL-17 family cytokines in periodontal disease
Awang, R. A. (2014) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Étude des mécanismes de la récidive du syndrome néphrotique idiopathique après transplantation rénale
Bruneau, S. (2009)
Receptor for advanced glycation endproducts mediates allergic airway inflammation via group 2 innate lymphoid cells
Oczypok, E. A. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Effects of IL-33 on the interaction between HMC-1 cells and human airway smooth muscle cells
Jones, R. (2009) · Enlighten: Theses (The University of Glasgow)
The role of the cytokines IL-17A and IL-33 in inflammatory arthritis and psoriasis
Hueber, A. J. (2011) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.2629
The functional biology of IL-25
Saenz, S. A. (2011) · Scholarly Commons (University of Pennsylvania)
The role of IL 33/ST2 pathway in innate immune response in airway inflammation
Stolarski, B. (2011) · Enlighten: Theses (The University of Glasgow)
A genetic and functional analysis of novel chicken interleukin-1 gene family members
Gibson, M. S. (2012) · UCL Discovery (University College London)
Mast cell responses to danger signals
Enoksson, M. (2012) · Figshare
Research of Immunology Markers of UC
Díaz-Jiménez, D., Katya Carrillo, G., Quera, R., & Marcela, A. (2012) · InTech eBooks · doi:10.5772/28097
Genetic epidemiology of atopy and asthma
Wan, Y. I. (2011) · Nottingham ePrints (University of Nottingham)
Fas Pathway of Cell Death and B Cell Dysregulation in SLE
Paganelli, R., Paganelli, A., & Maria, C. (2012) · InTech eBooks · doi:10.5772/26509
News in the pathophysiology of asthma
Martinović, M. (2013) · Vojnosanitetski pregled · doi:10.2298/vsp1308768m · Cited by 1
Anti-fungal effect of IL-33: Regulation of neutrophil activities by IL-33
Cho, H. R., & Kwon, B. (2012) · International Forum on Strategic Technology · doi:10.1109/ifost.2012.6357820
Emerging roles of IL-33 in inflammation and immune regulation
Ikutani, M., Tsuneyama, K., Nakae, S., & Takatsu, K. (2015) · Inflammation and Regeneration · doi:10.2492/inflammregen.35.069
L’IL-33, une nouvelle cytokine de la famille IL-1 impliquée dans l’allergie
Girard, J. (2010) · Revue française d'allergologie · doi:10.1016/j.reval.2010.02.003
Self-citation
L’interleukine-33 : un nouvel acteur dans l’ostéonécrose de la tête fémorale ?
Saïdi, S., & Magne, D. (2011) · Revue du Rhumatisme · doi:10.1016/j.rhum.2011.06.002
Role of HMGB1 in cells of the circulation
Rouhiainen, A. (2008) · Työväentutkimus Vuosikirja
Paradoxes and Pitfalls of Interleukin-33 in Atherosclerosis
Kunes, P. (2012) · The Open Clinical Chemistry Journal · doi:10.2174/1874241601205010013
L’interleukine-33 : une cible thérapeutique potentielle de la néo-angiogenèse associée à l’asthme
Glineur, C., Duez, C., & Tsicopoulos, A. (2015) · Revue française d'allergologie · doi:10.1016/j.reval.2015.06.004
News in the pathophysiology of asthma Novine u patofiziologiji astme
Martinovi, M. (2013)
Traumatic brain injury and brain tumour
Wicher, G., & Nilsson, K. (2012)
Antiviral responses to dengue virus
Bosch, I., & Muñoz‐Jordán, J. L. (2009) · Salus Journal of Health Sciences
Identification de déterminants génétiques impliqués dans la composante vasculaire de la MA, par analyses transcriptomiques, génétiques et moléculaires
Chapuis, J. (2008) · HAL
Mechanisms of palmitate induced amyloidogenesis in Alzheimer's Disease mediated by astrocytes
Liu, L. (2013) · doi:10.25335/hzqa-1c05
Role of IL-33 in allergic inflammation and diseases
Kouzaki, H. (2011) · 耳鼻咽喉科免疫アレルギー · doi:10.5648/jjiao.29.241
Retracted
Untersuchung der Expression und Regulation von Komponenten des Inflammasoms in primären intestinalen Epithelzellen, Zelllinien, sowie bei Patienten mit Morbus Crohn und Colitis ulcerosa
Medizin, I. (2009)
EFEITOS ANTIESPASMÓDICO E MIORRELAXANTE DO β-CITRONELOL EM MÚSCULO LISO TRAQUEAL DE RATOS: POTENCIAL AÇÃO NA HIPERREATIVIDADE APÓS DESAFIO ANTIGÊNICO E ELUCIDAÇÃO DO MECANISMO DE AÇÃO
Pós-Graduação, P. D. (2013)
The role of IL-33 and ST2 in innate and adaptive inflammation
Kewin, P. (2007) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.71136
CCR2Cell Mobilization Depends upon Induced Hematopoietic Stem and - IL-33
Kwon, B., Kim, B.-S., Jun, J., Cho, H. R., Tran, V. G., Kim, H. J., Jung, S., Kim, W., Le, T. X., & Moon, U. J. (2014)
IL-36 member activation and secretion, and their role in immune defence
Macleod, T. J. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Regulation of IL-33 Expression by IFN-c and Tumor Necrosis Factor-a in Normal Human Epidermal
Meephansan, K., Tsuda, H., Komine, M., & Tominaga, S. (2012)
Genetic and environmental influences on the development of allergic pulmonary disease
Sherburn, R. T. (2015) · doi:10.25560/46042
Damage-associated Molecular Patterns
Cavaillon, J. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch3 · Cited by 1
Characterization of Interleukin-33 and the IL-33 receptor complex
Ali, S., & Justus Liebig University Giessen (2009) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-10134

Authors: Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P.
Affiliations: *Laboratoire de Biologie Vasculaire, Equipe Labellisée “La Ligue 2006,” Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5089, 205 Route de Narbonne, 31077 Toulouse, France; and
Centre National de la Recherche Scientifique (FR)
Endocube, Prologue Biotech, BP700, Rue Pierre et Marie Curie, 31319 Labège Cedex, France
Corresponding author: Girard, Jean-Philippe
ORCID: Roussel, Lucie
Aguilar, Luc
Girard, Jean-Philippe
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2007-01-02
Volume: 104
Issue: 1
Pages: 282-287
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0606854104
PMC: PMC1765450
OpenAlex: W2093396768
Cited by: 966
References: 38
Citations by year: 2026: 20 · 2025: 29 · 2024: 30 · 2023: 49 · 2022: 50 · 2021: 51 · 2020: 47 · 2019: 51 · 2018: 58 · 2017: 55 · 2016: 64 · 2015: 70 · 2014: 52 · 2013: 56 · 2012: 72
FWCI: 12.14
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Association pour la Recherche sur le Cancer
Drug Applied Research Center, Tabriz University of Medical Sciences
Topics: Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: IL-33, ST2 receptor, heterochromatin, nuclear factors, transcriptional repressor, endothelial cells, high endothelial venules, rheumatoid arthritis, Crohn's disease, chronic inflammation, HMGB1
MeSH terms: Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Animals, Arthritis, Rheumatoid, Crohn Disease, HeLa Cells, Heterochromatin, Humans, Interleukins, Membrane Proteins, Mitosis, Nuclear Proteins, Receptors, Cell Surface, Repressor Proteins, RNA, Messenger, 3T3 Cells, Conserved Sequence, Receptors, Interleukin, Nuclear Localization Signals, Amino Acid Motifs, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks